What are the clinical indications for using CMV seronegative products?
CMV seronegative products should be used for:
* Pregnant women requiring regular elective transfusions during pregnancy
* Recipients of intrauterine transfusions (IUT)
* Neonates (up to 28 days post expected date of delivery)
* Granulocyte transfusions for CMV negative patients
CMV refers to cytomegalovirus, which can pose risks during transfusions in certain populations.
In what situations will the use of CMV seronegative or leucodepleted blood products be dictated?
The use will be dictated by local clinical policies for:
* Solid organ transplants
* Haemopoietic stem cell transplants (HSCT)
* Haematology and oncology patients
* Immunodeficient patients, including those with HIV
Leucodepleted blood products are designed to reduce the risk of CMV transmission.
True or False: CMV seronegative products can be used during delivery for pregnant women.
False
The guidelines specify use during pregnancy but not during delivery.
Fill in the blank: CMV seronegative products are recommended for _______ during pregnancy.
[pregnant women requiring regular elective transfusions]
This recommendation applies regardless of the CMV status of the pregnant women.
What is the maximum age for neonates to receive CMV seronegative products?
Up to 28 days post expected date of delivery
This age limit is crucial to ensure safety in transfusion practices.
10 tips to manage blood inventory
- Understand your inventory
- Provide expert training
- Set appropriate inventory levels
- Keep procedures simple
